NO20040382L - Kinolinderivater og anvendelse derav som antitumormidler - Google Patents

Kinolinderivater og anvendelse derav som antitumormidler

Info

Publication number
NO20040382L
NO20040382L NO20040382A NO20040382A NO20040382L NO 20040382 L NO20040382 L NO 20040382L NO 20040382 A NO20040382 A NO 20040382A NO 20040382 A NO20040382 A NO 20040382A NO 20040382 L NO20040382 L NO 20040382L
Authority
NO
Norway
Prior art keywords
formula
compound
antitumor agents
quinoline derivatives
salt
Prior art date
Application number
NO20040382A
Other languages
English (en)
Other versions
NO326463B1 (no
Inventor
Thomas Hughes Corbett
Jerome P Horwitz
Stewart T Hazeldine
Lisa Polin
Original Assignee
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wayne State filed Critical Univ Wayne State
Publication of NO20040382L publication Critical patent/NO20040382L/no
Publication of NO326463B1 publication Critical patent/NO326463B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
NO20040382A 2001-07-31 2004-01-28 Kinolinderivater og sammensetninger omfattende nevnte derivater, samt anvendelser derav i medisinsk terapi, sa som ned behandling av kreft NO326463B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30914401P 2001-07-31 2001-07-31
PCT/US2002/024442 WO2003011832A1 (en) 2001-07-31 2002-07-31 Quinoline derivatives and use thereof as antitumor agents

Publications (2)

Publication Number Publication Date
NO20040382L true NO20040382L (no) 2004-03-26
NO326463B1 NO326463B1 (no) 2008-12-08

Family

ID=23196886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040382A NO326463B1 (no) 2001-07-31 2004-01-28 Kinolinderivater og sammensetninger omfattende nevnte derivater, samt anvendelser derav i medisinsk terapi, sa som ned behandling av kreft

Country Status (22)

Country Link
US (3) US6867219B2 (no)
EP (1) EP1412332B1 (no)
JP (1) JP4310185B2 (no)
KR (1) KR20040055774A (no)
AT (1) ATE287397T1 (no)
AU (1) AU2002355747B2 (no)
CA (1) CA2456173A1 (no)
DE (1) DE60202682T2 (no)
DK (1) DK1412332T3 (no)
EA (1) EA007205B1 (no)
ES (1) ES2236548T3 (no)
GE (1) GEP20063754B (no)
HU (1) HUP0401562A2 (no)
IL (2) IL160082A0 (no)
MX (1) MXPA04000968A (no)
NO (1) NO326463B1 (no)
NZ (1) NZ530806A (no)
PL (1) PL367340A1 (no)
PT (1) PT1412332E (no)
UA (1) UA75691C2 (no)
WO (1) WO2003011832A1 (no)
ZA (1) ZA200401185B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60115394T2 (de) * 2000-02-29 2006-10-19 Millennium Pharmaceuticals, Inc., Cambridge Benzamide und ähnliche inhibitoren vom faktor xa
PL367340A1 (en) * 2001-07-31 2005-02-21 Wayne State University Quinoline derivatives and use thereof as antitumor agents
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
RU2322236C2 (ru) * 2002-08-24 2008-04-20 Центарис Гмбх Лекарственное средство для лечения доброкачественных и злокачественных опухолевых заболеваний, содержащее производное дисоразола
US8183379B2 (en) 2005-09-07 2012-05-22 Wayne State University Antitumor agents
US20070054938A1 (en) * 2005-09-07 2007-03-08 Horwitz Jerome P Antitumor agents
US7470788B2 (en) 2005-09-07 2008-12-30 Wayne State University Antitumor agents
EP1897542A1 (en) * 2006-09-07 2008-03-12 Sanofi-Aventis Aqueous formulation comprising an antitumor agent
JO2685B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
WO2009002955A1 (en) * 2007-06-27 2008-12-31 Sanofi-Aventis U.S. Llc Process for the preparation of (2r)-2-[4-(7-bromo-2-quinolyloxy)phenoxy]propanoic acid
US8809562B2 (en) 2011-06-06 2014-08-19 Chevron Phillips Chemical Company Lp Use of metallocene compounds for cancer treatment
WO2024132001A1 (en) * 2022-12-21 2024-06-27 Charles University, Faculty Of Pharmacy In Hradec Kralove Multitarget nuclear receptor ligands based on 2-(4-(quinolin-2-yloxy)phenoxy)propanoic acid and 2-(4-(quinoxalin-2-yloxy)phenoxy)propanoic acid for the treatment of metabolic and liver diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033389B2 (ja) * 1979-02-22 1985-08-02 日産化学工業株式会社 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤
US6197728B1 (en) 1980-08-06 2001-03-06 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US5364831A (en) 1980-08-06 1994-11-15 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US5250690A (en) * 1985-05-02 1993-10-05 Dowelanco Haloalkoxy anilide derivatives of 2-4(-heterocyclic oxyphenoxy)alkanoic or alkenoic acids and their use as herbicides
PL367340A1 (en) * 2001-07-31 2005-02-21 Wayne State University Quinoline derivatives and use thereof as antitumor agents
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
US7470788B2 (en) * 2005-09-07 2008-12-30 Wayne State University Antitumor agents

Also Published As

Publication number Publication date
GEP20063754B (en) 2006-02-27
DE60202682D1 (de) 2005-02-24
ATE287397T1 (de) 2005-02-15
JP4310185B2 (ja) 2009-08-05
US20050159447A1 (en) 2005-07-21
AU2002355747B2 (en) 2007-12-20
NO326463B1 (no) 2008-12-08
US6867219B2 (en) 2005-03-15
PL367340A1 (en) 2005-02-21
US7241894B2 (en) 2007-07-10
EP1412332B1 (en) 2005-01-19
EA007205B1 (ru) 2006-08-25
US20070232643A1 (en) 2007-10-04
HUP0401562A2 (hu) 2004-12-28
IL160082A0 (en) 2004-06-20
NZ530806A (en) 2006-05-26
UA75691C2 (en) 2006-05-15
WO2003011832A1 (en) 2003-02-13
KR20040055774A (ko) 2004-06-26
CA2456173A1 (en) 2003-02-13
JP2004538314A (ja) 2004-12-24
US20030144321A1 (en) 2003-07-31
IL160082A (en) 2009-06-15
DK1412332T3 (da) 2005-05-30
ES2236548T3 (es) 2005-07-16
EP1412332A1 (en) 2004-04-28
MXPA04000968A (es) 2005-02-17
DE60202682T2 (de) 2005-12-29
US7507749B2 (en) 2009-03-24
ZA200401185B (en) 2004-10-21
EA200400219A1 (ru) 2004-12-30
PT1412332E (pt) 2005-06-30

Similar Documents

Publication Publication Date Title
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
DK1539700T3 (da) 8-hydroxyquinolin-derivater
EA200700099A1 (ru) Производные пиридина
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
ATE264852T1 (de) Chinolinderivate als antibakterielle mittel
NO20060973L (no) Pyridylderivater og deres anvendelse som tempeutiske midler
MX2007004740A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica.
DK1412332T3 (da) Quinolinderivater og anvendelse deraf som antitumormidler
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
SE0102440D0 (sv) New compound
SE0401655D0 (sv) New compounds
ATE390923T1 (de) Topoisomerase-giftmittel
ATE424200T1 (de) Solubilisierte topoisomerase-gift-mittel
ATE308540T1 (de) Antithrombosemittel
TNSN08093A1 (en) Quinoline derivatives and use as antitumor agents
SE9900190D0 (sv) New compounds
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
ATE301997T1 (de) Antivirale therapie
TW200744596A (en) Antitumor agents
EA200500860A1 (ru) Фармацевтическая композиция, содержащая антагонист ltb4 и ингибитор cox2 или комбинированный ингибитор cox1/cox2

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees